Patents by Inventor Sonia Tugues

Sonia Tugues has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LIGANDS TO GM-CSF OR GM-CSF-RECEPTOR FOR USE IN LEUKEMIA IN A PATIENT HAVING UNDERGONE ALLO-HCT
    Publication number: 20230340100
    Abstract: Described herein is the use of a non-agonist ligand, particularly an antibody, specifically binding to GM-CSF or one of CD116, CD131 and the GM-CSF receptor composed of CD116 and CD131 for use in treatment of leukemia in a patient having undergone allo-HCT or in treatment of other complications arising as a consequence of hematopoietic cell transplantation from an immunologically non-identical donor.
    Type: Application
    Filed: May 18, 2023
    Publication date: October 26, 2023
    Applicant: UNIVERSITAT ZURICH
    Inventors: Burkhard BECHER, Sonia TUGUES
  • Ligands to GM-CSF or GM-CSF-receptor for use in leukemia in a patient having undergone allo-HCT
    Patent number: 11655293
    Abstract: Described herein is the use of a non-agonist ligand, particularly an antibody, specifically binding to GM-CSF or one of CD116, CD131 and the GM-CSF receptor composed of CD116 and CD131 for use in treatment of leukemia in a patient having undergone allo-HCT or in treatment of other complications arising as a consequence of hematopoietic cell transplantation from an immunologically non-identical donor.
    Type: Grant
    Filed: February 7, 2019
    Date of Patent: May 23, 2023
    Assignee: UNIVERSITAT ZURICH
    Inventors: Burkhard Becher, Sonia Tugues
  • LIGANDS TO GM-CSF OR GM-CSF-RECEPTOR FOR USE IN TREATMENT OF A HAEMATOLOGIC MALIGNANCY IN A PATIENT HAVING UNDERGONE ALLO-HCT
    Publication number: 20210070851
    Abstract: Described herein is the use of a non-agonist ligand, particularly an antibody, specifically binding to GM-CSF or one of CD116, CD131 and the GM-CSF receptor composed of CD116 and CD131 for use in treatment of leukemia in a patient having undergone allo-HCT or in treatment of other complications arising as a consequence of hematopoietic cell transplantation from an immunologically non-identical donor.
    Type: Application
    Filed: February 22, 2019
    Publication date: March 11, 2021
    Applicant: UNIVERSITÄT ZÜRICH
    Inventors: Sonia TUGUES, Burkhard BECHER
  • Ligands to GM-CSF or GM-CSF-Receptor for use in Leukemia in a Patient Having undergone Allo-HCT
    Publication number: 20190256587
    Abstract: Described herein is the use of a non-agonist ligand, particularly an antibody, specifically binding to GM-CSF or one of CD116, CD131 and the GM-CSF receptor composed of CD116 and CD131 for use in treatment of leukemia in a patient having undergone allo-HCT or in treatment of other complications arising as a consequence of hematopoietic cell transplantation from an immunologically non-identical donor.
    Type: Application
    Filed: February 7, 2019
    Publication date: August 22, 2019
    Applicant: UNIVERSITAT ZURICH
    Inventors: Burkhard Becher, Sonia Tugues